Bonesupport: Q2, Continuing its positive trajectory with significant catalysts inching in - Redeye

Redeye continues to have a positive outlook on the fundamental prospects of BONESUPPORT following today’s report. H2 2021 entails several potentially case cementing and even altering events that could have significant positive impacts on its fundamental basis as well as the development of the share in the nearer term.

https://www.redeye.se/research/817122/bonesupport-q2-continuing-its-positive-trajectory-with-significant-catalysts-inching-in?utm_source=finwire&utm_medium=RSS